Brugada Syndrome
A guide to Brugada syndrome, ECG patterns, fever precautions, family assessment and prevention of sudden cardiac death.
Brugada syndrome is an inherited electrical disorder associated with characteristic right-precordial ECG changes and a variable risk of dangerous ventricular arrhythmias. A Brugada-like ECG pattern can also appear because of fever, medicines, electrolyte abnormalities or other conditions, so specialist interpretation is essential.
Evaluation
Assessment includes the ECG pattern, symptoms such as unexplained fainting or nocturnal agonal breathing, family history and circumstances surrounding any cardiac arrest. Repeated ECGs or higher right-precordial lead positions may be useful. Genetic testing can support family evaluation but does not replace clinical assessment.
Risk Reduction
Fever should be treated promptly, and medicines known to provoke a Brugada ECG pattern should be avoided after professional review. An implantable cardioverter defibrillator is generally reserved for patients with a sufficiently high arrhythmic risk; it is not recommended solely because of an incidental low-risk pattern.
Seek urgent care for fainting, seizure-like episodes, sustained palpitations or fever accompanied by concerning symptoms.
Clinical Depth and Risk Assessment
Risk is not defined by the diagnostic label alone. Symptoms, ECG and rhythm findings, ventricular function, myocardial scar or structural change, family history, associated disease and previous events are integrated. Genetic results, when relevant, require expert interpretation; a variant of uncertain significance is not equivalent to a diagnosis.
Diagnostic Strategy and Limitations
Testing is selected to answer a specific question. ECG, ambulatory monitoring, echocardiography, cardiac MRI, CT, laboratory testing, exercise assessment or invasive evaluation have complementary roles. A normal test may not exclude an intermittent disorder, while an abnormal measurement must be checked against technical quality and clinical probability.
Treatment Decision Framework
Treatment may combine risk-factor control, condition-specific medicines, rhythm or heart-failure therapy, catheter procedures, surgery and implanted devices. These options address different mechanisms and are not automatically substitutes for one another. Expected benefit, uncertainty, procedural burden and the patient’s informed preferences should be discussed explicitly.
Long-Term Follow-up
Follow-up assesses symptoms, exercise capacity, rhythm burden, ventricular function and treatment tolerance over time. Family screening may be appropriate in inherited or suspected inherited disease. New fainting, sustained rapid rhythm, chest pain, neurological symptoms or rapidly worsening breathlessness requires urgent assessment.
Questions to Discuss With the Cardiology Team
- Which finding has the greatest influence on my present risk?
- Which test or treatment would genuinely change management?
- What symptoms should lead to an earlier appointment or emergency care?
- Do relatives need clinical or genetic assessment?
Medical Information Note
This page supports an informed discussion with the clinical team. It does not provide a personal diagnosis, medicine dose or sports-clearance decision.